These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 22370974)

  • 21. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
    Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
    Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter).
    Kim YK; Lee MW; Lee WJ; Kim SH; Rhim H; Lim JH; Choi D; Kim YS; Jang KM; Lee SJ; Lim HK
    Invest Radiol; 2012 Mar; 47(3):159-66. PubMed ID: 22330426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE; Kim SH; Lee SJ; Rhim H
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion-weighted imaging of the liver in patients with chronic liver disease: comparison of monopolar and bipolar diffusion gradients for image quality and lesion detection.
    Lewis S; Kamath A; Chatterji M; Patel A; Shyknevsky I; Dyvorne HA; Kuehn B; Taouli B
    AJR Am J Roentgenol; 2015 Jan; 204(1):59-68. PubMed ID: 25539238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma.
    Kim YK; Kim YK; Park HJ; Park MJ; Lee WJ; Choi D
    Magn Reson Imaging; 2014 Jul; 32(6):610-8. PubMed ID: 24702980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T.
    Wang H; Wang XY; Jiang XX; Ye ZX
    Acad Radiol; 2010 Feb; 17(2):239-43. PubMed ID: 19962912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
    Piana G; Trinquart L; Meskine N; Barrau V; Beers BV; Vilgrain V
    J Hepatol; 2011 Jul; 55(1):126-32. PubMed ID: 21145857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is gadoxetic acid-enhanced MRI limited in tumor characterization for patients with chronic liver disease?
    Kwon S; Kim YK; Park HJ; Jeong WK; Lee WJ; Choi D
    Magn Reson Imaging; 2014 Dec; 32(10):1214-22. PubMed ID: 25192607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.
    Parikh T; Drew SJ; Lee VS; Wong S; Hecht EM; Babb JS; Taouli B
    Radiology; 2008 Mar; 246(3):812-22. PubMed ID: 18223123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of focal liver lesions with gadoxetic acid-enhanced MRI: is a shortened delay time possible by adding diffusion-weighted imaging?
    Kim MY; Kim YK; Park HJ; Park MJ; Lee WJ; Choi D
    J Magn Reson Imaging; 2014 Jan; 39(1):31-41. PubMed ID: 24115329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma.
    Saito K; Araki Y; Park J; Metoki R; Katsuyama H; Nishio R; Kakizaki D; Moriyasu F; Tokuuye K
    J Magn Reson Imaging; 2010 Jul; 32(1):229-34. PubMed ID: 20578029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of small (≤2 cm) HCC in cirrhotic patients: added value of diffusion MR-imaging.
    Di Martino M; Di Miscio R; De Filippis G; Lombardo CV; Saba L; Geiger D; Catalano C
    Abdom Imaging; 2013 Dec; 38(6):1254-62. PubMed ID: 23857505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion weighted MR imaging in patients with HCC and liver cirrhosis after administration of different gadolinium contrast agents: is it still reliable?
    Kinner S; Umutlu L; Blex S; Maderwald S; Antoch G; Ertle J; Gerken G; Lauenstein TC
    Eur J Radiol; 2012 Apr; 81(4):e625-8. PubMed ID: 22297185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.
    Yu JS; Kim JH; Chung JJ; Kim KW
    J Magn Reson Imaging; 2009 Jul; 30(1):153-60. PubMed ID: 19557734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.
    Becker-Weidman DJ; Kalb B; Sharma P; Kitajima HD; Lurie CR; Chen Z; Spivey JR; Knechtle SJ; Hanish SI; Adsay NV; Farris AB; Martin DR
    Radiology; 2011 Dec; 261(3):824-33. PubMed ID: 21969663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience.
    Lauenstein TC; Salman K; Morreira R; Heffron T; Spivey JR; Martinez E; Sharma P; Martin DR
    AJR Am J Roentgenol; 2007 Sep; 189(3):663-70. PubMed ID: 17715115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does T2-weighted MR imaging improve preoperative detection of malignant hepatic tumors? Observer performance study in 49 surgically proven cases.
    Kondo H; Kanematsu M; Itoh K; Ito K; Maetani Y; Goshima S; Matsuo M; Matsunaga N; Konishi J; Hoshi H; Moriyama N
    Magn Reson Imaging; 2005 Jan; 23(1):89-95. PubMed ID: 15733793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.